TickerFactsScreenerDevelopers

MoonLake Immunotherapeutics (MLTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2021: -$4.57M2022: -$65.06M2023: -$54.12M2024: -$143.09M2025: -$244.83M-$244.83M
2021Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$244.83M-71.1%
2024-$143.09M-164.4%
2023-$54.12M+16.8%
2022-$65.06M-1323.6%
2021-$4.57M—